Skip to main content
OpenTrials
Completed

NCT Number: NCT01107431

Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin

This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pre-diabetes Glucose Intolerance Glucose Metabolism Disorders Hyperglycemia Hyperinsulinism Insulin Resistance Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Integrative Health Technologies

San Antonio, Texas, 78209, United States

About this study

This study concluded that consumption of the LA-Cr supplement in conjunction with a 70-gram sucrose challenge led to a significant reduction of capillary blood glucose and venous insulin as compared to the sucrose challenge without the LA-Cr supplement. This finding may provide an important tool to reduce the adverse effects associated with elevated glucose and insulin levels.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All study subjects were required to contact their family physician to ensure they had no medical conditions that would preclude their participation.

Exclusion criteria

  • Diabetics, and
  • Those not approved by their physicians.

Treatment and study plan

L-Arabinose and Chromium

Dietary Supplement

Consumed 70 grams of sucrose simultaneously taking a dietary supplement

Other names: 70 grams of cane sugar along with supplement

Sucrose without dietary Supplement

Dietary Supplement

Repeated measures on subjects taking 70 grams of sucrose along with taking a dietary supplement containing L-Arabinose and Chromium

Other names: 70 grams of cane sugar with supplement

Primary outcomes

  1. Fasting Blood Glucose

    Time frame: Every 15 to 30 minutes

    Finger-stick glucose measurements taken every 15 or 30 minutes after taking a 70 gram sucrose challenge with and without the dietary supplement

Secondary outcomes

  1. Fasting Blood Insulin Levels

    Time frame: Every 30 minutes

    A venipuncture blood test taken 30, 60, 90 and 120 minutes after taking a 70 gram sucrose challenge with and without taking the dietary supplement

Sponsors and collaborators

Lead sponsor

Integrative Health Technologies, Inc.

Network

Registry information

Official study title

A Combination of L-Arabinose and Chromium Lowers Circulating Glucose and Insulin Levels After Acute Oral Sucrose Challenge

Acronym: L-Arabinose

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Apr 21, 2010
Registry last updated
May 13, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.